Prestige Consumer Healthcare entered into an amendment to its Term Loan Credit Agreement to permit up to $95 million of additional term loans to help finance the LaCorium Acquisition and related fees. The amendment was executed on July 1, 2026, and became effective the same day. The company’s subsidiary borrowed the full $95 million upon closing to complete the acquisition.
Agreement details:
- Agreement type: Amendment to Term Loan Credit Agreement permitting up to $95 million incremental term loans
- Counterparty: Citibank as administrative agent and the lenders
- Signed / Effective: Jul 01 2026 / same
- Reason: Finance LaCorium Acquisition and related costs
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.